Literature DB >> 26457909

Geographic access to hematopoietic cell transplantation services in the United States.

P L Delamater1, J P Uberti2.   

Abstract

The use of hematopoietic cell transplantation (HCT) has risen in recent years and additional increases are projected in the near- and long-term future. The complex nature of HCT, along with its potentially rigorous follow-up care requirements, presents numerous potential barriers to accessing this important service (for example, financial considerations, donor availability and sociodemographic factors). The distance between a patient and an HCT facility also appears to be an important factor in both HCT use and outcomes. We provide the first comprehensive and detailed evaluation of geographic access to HCT services for the adult (18+ years) and pediatric (0-17 years) populations in the United States. Population-level access is examined as well as detailed gender, race/ethnicity and age breakdowns. Generally, access to HCT services appears to be quite high throughout the United States, as 48%, 78.6% and 94.7% of the 18+ years age population has 30, 90 and 180 min access (respectively) to an adult HCT facility and 42.5%, 72% and 91.5% of the 0-17 years age population has 30, 90 and 180 min access (respectively) to a pediatric facility.

Entities:  

Mesh:

Year:  2015        PMID: 26457909     DOI: 10.1038/bmt.2015.246

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  15 in total

1.  National Survey of Hematopoietic Cell Transplantation Center Personnel, Infrastructure, and Models of Care Delivery.

Authors:  Navneet S Majhail; Lih-Wen Mau; Pintip Chitphakdithai; Tammy Payton; Michael Eckrich; Steven Joffe; Stephanie J Lee; Charles F LeMaistre; Jennifer LeRademacher; Fausto Loberiza; Brent Logan; Susan K Parsons; Ramona Repaczki-Jones; Pam Robinett; J Douglas Rizzo; Elizabeth Murphy; Ellen M Denzen
Journal:  Biol Blood Marrow Transplant       Date:  2015-03-31       Impact factor: 5.742

2.  Estimating demand and unmet need for allogeneic hematopoietic cell transplantation in the United States using geographic information systems.

Authors:  Kelsey L Besse; Jaime M Preussler; Elizabeth A Murphy; Ellen M Denzen; Michael C Lill; Jeffrey W Chell; Mary K Senneka; Navneet S Majhail; Eric P Williams
Journal:  J Oncol Pract       Date:  2015-03       Impact factor: 3.840

Review 3.  Racial disparities in hematopoietic cell transplantation in the United States.

Authors:  N S Majhail; S Nayyar; M E Burton Santibañez; E A Murphy; E M Denzen
Journal:  Bone Marrow Transplant       Date:  2011-11-07       Impact factor: 5.483

4.  Practice variation in physician referral for allogeneic hematopoietic cell transplantation.

Authors:  J Pidala; B M Craig; S J Lee; N Majhail; G Quinn; C Anasetti
Journal:  Bone Marrow Transplant       Date:  2012-06-18       Impact factor: 5.483

5.  Prevalence of hematopoietic cell transplant survivors in the United States.

Authors:  Navneet S Majhail; Li Tao; Christopher Bredeson; Stella Davies; Jason Dehn; James L Gajewski; Theresa Hahn; Ann Jakubowski; Steven Joffe; Hillard M Lazarus; Susan K Parsons; Kim Robien; Stephanie J Lee; Karen M Kuntz
Journal:  Biol Blood Marrow Transplant       Date:  2013-07-30       Impact factor: 5.742

6.  Access to hematopoietic stem cell transplantation: effect of race and sex.

Authors:  Thomas V Joshua; J Douglas Rizzo; Mei-Jie Zhang; Parameswaran N Hari; Seira Kurian; Marcelo Pasquini; Navneet S Majhail; Stephanie J Lee; Mary M Horowitz
Journal:  Cancer       Date:  2010-07-15       Impact factor: 6.860

7.  The impact of geographic proximity to transplant center on outcomes after allogeneic hematopoietic stem cell transplantation.

Authors:  Karim E Abou-Nassar; Haesook T Kim; Jeff Blossom; Vincent T Ho; Robert J Soiffer; Corey S Cutler; Edwin P Alyea; John Koreth; Joseph H Antin; Philippe Armand
Journal:  Biol Blood Marrow Transplant       Date:  2011-09-08       Impact factor: 5.742

Review 8.  Allogeneic transplant physician and center capacity in the United States.

Authors:  Navneet S Majhail; Elizabeth A Murphy; Nancy A Omondi; Pam Robinett; James L Gajewski; C Fred LeMaistre; Dennis Confer; J Douglas Rizzo
Journal:  Biol Blood Marrow Transplant       Date:  2011-04-12       Impact factor: 5.742

9.  Disparity in survival outcome after hematopoietic stem cell transplantation for hematologic malignancies according to area of primary residence.

Authors:  Keshav Rao; Deborah L Darrington; Joseph J Schumacher; Marcel Devetten; Julie M Vose; Fausto R Loberiza
Journal:  Biol Blood Marrow Transplant       Date:  2007-12       Impact factor: 5.742

Review 10.  Access to hematopoietic cell transplantation in the United States.

Authors:  Navneet S Majhail; Nancy A Omondi; Ellen Denzen; Elizabeth A Murphy; J Douglas Rizzo
Journal:  Biol Blood Marrow Transplant       Date:  2009-12-28       Impact factor: 5.742

View more
  8 in total

1.  Inferior Access to Allogeneic Transplant in Disadvantaged Populations: A Center for International Blood and Marrow Transplant Research Analysis.

Authors:  Kristjan Paulson; Ruta Brazauskas; Nandita Khera; Naya He; Navneet Majhail; Gorgun Akpek; Mahmoud Aljurf; David Buchbinder; Linda Burns; Sara Beattie; Cesar Freytes; Anne Garcia; James Gajewski; Theresa Hahn; Jennifer Knight; Charles LeMaistre; Hillard Lazarus; David Szwajcer; Matthew Seftel; Baldeep Wirk; William Wood; Wael Saber
Journal:  Biol Blood Marrow Transplant       Date:  2019-06-19       Impact factor: 5.742

2.  Increasing access to allogeneic hematopoietic cell transplant: an international perspective.

Authors:  Vanderson Rocha; Giancarlo Fatobene; Dietger Niederwieser
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 3.  Increasing access to allotransplants in the United States: the impact of race, geography, and socioeconomics.

Authors:  Sanghee Hong; Navneet S Majhail
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 4.  Role of CD19 Chimeric Antigen Receptor T Cells in Second-Line Large B Cell Lymphoma: Lessons from Phase 3 Trials. An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.

Authors:  Miguel-Angel Perales; Larry D Anderson; Tania Jain; Saad S Kenderian; Olalekan O Oluwole; Gunjan L Shah; Jakub Svoboda; Mehdi Hamadani
Journal:  Transplant Cell Ther       Date:  2022-06-26

5.  Willingness to Travel for Cellular Therapy: The Influence of Follow-Up Care Location, Oncologist Continuity, and Race.

Authors:  Zachary A K Frosch; Esin C Namoglu; Nandita Mitra; Daniel J Landsburg; Sunita D Nasta; Justin E Bekelman; Raghuram Iyengar; Carmen E Guerra; Marilyn M Schapira
Journal:  JCO Oncol Pract       Date:  2021-09-15

6.  Access to Hematopoietic Stem Cell Transplant in Canada for Patients with Acute Myeloid Leukemia.

Authors:  Oluwatobiloba Morakinyo; Oliver Bucher; Kristjan Paulson
Journal:  Curr Oncol       Date:  2022-07-22       Impact factor: 3.109

7.  Barriers to Hematopoietic Cell Transplantation for Adults in the United States: A Systematic Review with a Focus on Age.

Authors:  Colin Flannelly; Bryan E-Xin Tan; Jian Liang Tan; Colin M McHugh; Chandrika Sanapala; Tara Lagu; Jane L Liesveld; Omar Aljitawi; Michael W Becker; Jason H Mendler; Heidi D Klepin; Wendy Stock; Tanya M Wildes; Andrew Artz; Navneet S Majhail; Kah Poh Loh
Journal:  Biol Blood Marrow Transplant       Date:  2020-09-20       Impact factor: 5.609

8.  Driving Distance and Patient-Reported Outcomes in Hematopoietic Cell Transplantation Survivors.

Authors:  Rahul Banerjee; Jean C Yi; Navneet S Majhail; Heather S L Jim; Joseph Uberti; Victoria Whalen; Alison W Loren; Karen L Syrjala
Journal:  Biol Blood Marrow Transplant       Date:  2020-08-08       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.